Cancer screening in elderly patients: a framework for individualized decision making

Area of Science:

• Geriatric Medicine
• Oncology
• Clinical Decision-Making

Background:

• Cancer screening guidelines for older adults lack consensus, particularly regarding age cutoffs.
• Current guidelines often fail to account for individual patient variability in life expectancy and health status.

Purpose of the Study:

• To propose a framework for individualized cancer screening decisions in older patients.
• To emphasize the integration of quantitative data and patient values over rigid age-based recommendations.

Main Methods:

• Developing a framework that incorporates quantitative estimates of life expectancy, cancer death risk, and screening outcomes.
• Utilizing data on number needed to screen to prevent one cancer-specific death.
• Assessing potential harms of screening, including overdiagnosis, based on patient factors and test characteristics.

Main Results:

• Individualized benefit from cancer screening varies significantly, even among patients of similar ages.
• Patients with a life expectancy under 5 years are unlikely to gain survival benefits from cancer screening.
• The likelihood of harm, such as overdiagnosis, increases with decreasing life expectancy.

Conclusions:

• An individualized approach to cancer screening in older adults is superior to generalized age-based guidelines.
• Integrating quantitative risk-benefit analyses with patient values and preferences is essential for informed screening decisions.
• This framework supports clinicians in navigating complex cancer screening choices for elderly patients.